newsfilter
← Latest News
PR Newswire·

BioLineRx to Report 2024 Annual Results on March 31, 2025

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare...